MEDIWOUND LTD. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
MEDIWOUND LTD. (MDWD) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $15.38 per share as of 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2026-03-05
- 2025-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $15.38.
- 2024-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $20.79.
- 2023-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $26.25.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $46.18.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2025-12-31 | $15.38 20-F · filed 2026-03-05 | |
| 2024-12-31 | $20.79 20-F · filed 2026-03-05 | |
| 2023-12-31 | $26.25 20-F · filed 2026-03-05 | |
| 2022-12-31 | $46.18 20-F · filed 2025-03-19 | |
| 2021-12-31 | $58.38 20-F · filed 2024-03-21 | $8.34 20-F · filed 2022-03-17 |
| 2020-12-31 | $69.86 20-F · filed 2023-03-16 | $9.98 20-F · filed 2021-02-25 |
| 2019-12-31 | $4.76 20-F · filed 2022-03-17 | |
| 2018-12-31 | $11.23 20-F · filed 2021-02-25 | |
| 2017-12-31 | $10.25 20-F · filed 2020-02-25 |